BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18207320)

  • 21. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma].
    Huang JZ; Xia SS; Ye QF; Jiang HY
    Ai Zheng; 2003 Jan; 22(1):46-9. PubMed ID: 12561435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
    Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
    Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
    Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
    Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
    Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
    Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
    Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
    Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
    Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
    J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-catenin siRNA regulation of apoptosis- and angiogenesis-related gene expression in hepatocellular carcinoma cells: potential uses for gene therapy.
    Wang XH; Sun X; Meng XW; Lv ZW; Du YJ; Zhu Y; Chen J; Kong DX; Jin SZ
    Oncol Rep; 2010 Oct; 24(4):1093-9. PubMed ID: 20811694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma.
    Wu TT; Hsieh YH; Hsieh YS; Liu JY
    J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
    Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.
    Li GC; Ye QH; Xue YH; Sun HJ; Zhou HJ; Ren N; Jia HL; Shi J; Wu JC; Dai C; Dong QZ; Qin LX
    Cancer Sci; 2010 Dec; 101(12):2546-53. PubMed ID: 20942864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
    Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
    Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
    Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
    Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.